MEASURING PATIENT-RELEVANT TREATMENT BENEFIT IN DERMATOLOGY - DEVELOPMENT AND VALIDATION OF THE SHORT QUESTIONNAIRE "PATIENT BENEFIT INDEX 2.0"

被引：0
|
作者：
Blome, C. [1 ]
von Usslar, K. [1 ]
Augustin, M. [2 ]
机构：
[1] Univ Med Ctr Hamburg, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.044
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A330 / A330
页数：1
相关论文
共 50 条
  • [41] Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment
    Augustin, Matthias
    Sommer, Rachel
    Blome, Christine
    Kirsten, Natalia
    Langenbruch, Anna
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 1335 - 1345
  • [42] Patient-relevant benefit of sublingual immunotherapy (SLIT) with a 300 IR birch pollen extract in patients with allergic rhinoconjunctivitis
    Hadler, M.
    Karagiannis, E.
    Feuerhahn, J.
    Blome, C.
    Augustin, M.
    ALLERGY, 2016, 71 : 247 - 247
  • [43] Goals and benefits in topical treatment for psoriasis: development and pilot validation of a patient-reported outcomes tool, the Patient Benefit Index for Topical Treatment (PBI-TOP)
    Blome, Christine
    Huelswitt, Lennart
    Meineke, Anna
    Augustin, Matthias
    Ohm, Frenz
    Rusch, Judith
    Janke, Toni Maria
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (05) : 701 - 711
  • [44] A short generic patient experience questionnaire: howRwe development and validation
    Benson, Tim
    Potts, Henry W. W.
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [45] Development and validation of a new instrument for the assessment patient-defined benefit in the treatment of acne vulgaris
    Augustin, Matthias
    Reich, Christine
    Schaefer, Ines
    Zschocke, Ina
    Rustenbach, Stephan Jeff
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2008, 6 (02): : 113 - 120
  • [46] Development and validation of PSPSQ 2.0 measuring patient satisfaction with pharmacist services
    Sakharkar, Prashant
    Bounthavong, Mark
    Hirsch, Jan D.
    Morello, Candis M.
    Chen, Timothy C.
    Law, Anandi V.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2015, 11 (04): : 487 - 498
  • [47] PATIENT-RELEVANT ENDPOINTS (PRE) IN ONCOLOGY - CURRENT ISSUES IN THE CONTEXT OF EARLY BENEFIT ASSESSMENT (EBA) IN GERMANY: AN INDUSTRY PERSPECTIVE
    Dabisch, I
    Dethling, J.
    Dintsios, C. M.
    Drechsler, M.
    Kalanovic, D.
    Kaskel, P.
    Langer, F.
    Ruof, J.
    Ruppert, T.
    Wirth, D.
    VALUE IN HEALTH, 2012, 15 (07) : A437 - A437
  • [48] The Patient Benefit Index for topical treatment (PBI-TOP): a new questionnaire to assess the treatment goals and preferences of people with psoriasis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (05) : e56 - e56
  • [49] Concordance of psoriasis area and severity index (PASI) and patient relevant benefit in psoriasis-therapy
    Schaefer, I.
    Hacker, J.
    Rustenbach, S. J.
    Augustin, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 164 - 164
  • [50] Development and external validation of a prediction model for patient-relevant outcomes in patients with chronic widespread pain and fibromyalgia
    Moen, V. P.
    Tveter, A. T.
    Herbert, R. D.
    Hagen, K. B.
    EUROPEAN JOURNAL OF PAIN, 2022, 26 (05) : 1123 - 1134
12345